ApoE associated with lipid has a reduced capacity to inhibit β-amyloid fibril formation
- 1 October 1998
- journal article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 9 (14) , 3321-3323
- https://doi.org/10.1097/00001756-199810050-00031
Abstract
Apolipoprotein E (apoE) and the beta-amyloid peptide are both found in the senile plaques associated with Alzheimer's disease. Several studies have recently determined that apoE can prevent beta-amyloid fibril (Abetaf) formation in vitro. In vivo, apoE is normally associated with a lipid source. We show that both recombinant and purified plasma apoE inhibit Abetaf formation in a dose-dependent manner. The three major apoE isoforms were equipotent at inhibiting Abetaf formation. ApoE associated with either cholesterol-containing liposomes or very low density lipoproteins displayed less potent inhibition of Abetaf formation than their unlipidated counterparts. These results indicate that the presence of associated lipids reduce the ability of apoE to inhibit the formation of Abetaf in vitro.Keywords
This publication has 7 references indexed in Scilit:
- Concentration-Dependent Inhibitory Effects of Apolipoprotein E on Alzheimer's β-Amyloid Fibril Formation in VitroBiochemistry, 1997
- Soluble multimeric Alzheimer β(1–40) pre-amyloid complexes in dilute solutionNeurobiology of Aging, 1995
- Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein EBiochemical Journal, 1995
- Apolipoprotein E: Structure-Function RelationshipsAdvances in Protein Chemistry, 1994
- Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?Cell, 1993
- Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solutionProtein Science, 1993
- Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloidNeuroscience Letters, 1992